Groupe la Francaise Sells 7,414 Shares of Danaher Corporation $DHR

Groupe la Francaise decreased its holdings in Danaher Corporation (NYSE:DHR) by 21.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,621 shares of the conglomerate’s stock after selling 7,414 shares during the quarter. Groupe la Francaise’s holdings in Danaher were worth $5,070,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. High Note Wealth LLC increased its holdings in Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 47 shares in the last quarter. First Command Advisory Services Inc. increased its stake in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after purchasing an additional 47 shares in the last quarter. GW&K Investment Management LLC increased its stake in shares of Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after purchasing an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC raised its position in shares of Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, Gabelli Funds LLC lifted its stake in Danaher by 0.3% in the 4th quarter. Gabelli Funds LLC now owns 18,981 shares of the conglomerate’s stock valued at $4,345,000 after buying an additional 50 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Citigroup began coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, TD Cowen reduced their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Stock Down 0.1%

Shares of NYSE:DHR opened at $207.46 on Tuesday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a market cap of $145.84 billion, a price-to-earnings ratio of 36.85, a PEG ratio of 2.59 and a beta of 0.78. The stock’s 50-day moving average price is $202.03 and its two-hundred day moving average price is $192.15. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the firm posted $0.77 EPS. The company’s revenue was up 5.5% on a year-over-year basis. On average, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.